pyrazines has been researched along with Pulmonary Embolism in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Ako, J; Ikeda, Y; Joho, S; Kinoshita, H; Maki, H; Matoba, S; Motoki, H; Ogo, T; Saeki, T; Sakao, S; Shimokawahara, H; Shiota, N; Sugano, T; Takama, N; Tanabe, N; Tanaka, S; Tatsumi, K; Tsujino, I; Yamamoto, C; Yoshioka, K | 1 |
| Bedate-Diaz, P; Blasco-Esquivias, I; de Miguel-Diez, J; Fernandez-Capitan, C; Garcia-Fuika, S; Garcia-Lozaga, A; Garcia-Ortega, A; Jara-Palomares, L; Lobo-Beristain, JL; Lopez-Reyes, R; Marin-Barrera, L; Murga-Arizabaleta, I; Otero-Candelera, R; Praena-Fernandez, JM; Quezada, CA; RodrÃguez-Davila, MA; Rodriguez-Matute, C | 1 |
| Berlier, C; Lichtblau, M; Saxer, S; Schwarz, EI; Ulrich, S | 1 |
| Anderson, KC; Bladé, J; Cavenagh, J; Esseltine, DL; Harousseau, JL; Jakubowiak, AJ; Lonial, S; Rajkumar, SV; Richardson, PG; San Miguel, J; Schuster, MW; Sonneveld, P | 1 |
| Foks, H; Kaliszan, R; Petrusewicz, J; Pilarski, B; Turowski, M | 1 |
| Hsiao, G; Lee, YM; Sheu, JR; Yen, MH | 1 |
1 trial(s) available for pyrazines and Pulmonary Embolism
| Article | Year |
|---|---|
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
Topics: Acetamides; Antihypertensive Agents; Chronic Disease; Dyspnea; Humans; Hypertension, Pulmonary; Pulmonary Embolism; Pyrazines; Treatment Outcome | 2022 |
5 other study(ies) available for pyrazines and Pulmonary Embolism
| Article | Year |
|---|---|
Correlation between short-term air pollution exposure and unprovoked lung embolism. Prospective observational (Contamina-TEP Group).
Topics: Air Pollutants; Air Pollution; Environmental Exposure; Humans; Lung; Particulate Matter; Prospective Studies; Pulmonary Embolism; Pyrazines | 2020 |
Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis.
Topics: Acetamides; Aged; Antihypertensive Agents; Chronic Disease; Cohort Studies; Drug Therapy, Combination; Echocardiography; Endothelin Receptor Antagonists; Enzyme Activators; Exercise Test; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pulmonary Embolism; Pyrazines; Quality of Life; Retrospective Studies; Soluble Guanylyl Cyclase; Tricuspid Valve; Walk Test | 2019 |
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
Topics: Boronic Acids; Bortezomib; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Erythropoietin; Female; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pulmonary Embolism; Pyrazines; Recombinant Proteins; Recurrence; Risk; Treatment Outcome; Venous Thrombosis | 2008 |
Comparative studies of antiplatelet activity of nonsteroidal antiinflammatory drugs and new pyrazine CH- and NH-acids.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Epinephrine; Fibrinolytic Agents; Humans; Indomethacin; Ketorolac; Male; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Tolmetin | 1995 |
Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Pressure; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intravenous; Mesenteric Arteries; Mesenteric Veins; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Radiation Injuries, Experimental; Reproducibility of Results; Thrombolytic Therapy; Vasodilator Agents; Venous Thrombosis | 2001 |